GSK has announced a $30bn investment in the US over the next five years in research and development (R&D) and supply chain.

Drugmaker GSK said Wednesday it would invest $30 billion in U.S. research and development and supply chain infrastructure ...

The new projects, including AI efforts in Pennsylvania and three other states, are part of the British firm's pledge to ...

GSK will invest $30 billion in U.S. R&D and manufacturing, including a new biologics factory, AI upgrades, and expanded drug ...

GSK commits $30B to U.S. R&D and manufacturing, with advanced AI-driven biopharma facilities set to expand jobs and innovation.

GSK said the spending will help build new biologics facilities and upgrade existing plants in Pennsylvania, North Carolina, ...

GSK to invest $30 billion in R&D and supply chain infrastructure in US over next 5 years: London, UK Thursday, September 18, 2025, 11:00 Hrs [IST] GSK plc announced plans to inves ...

British pharmaceutical firm GSK has pledged to invest $30bn (£22bn) in research and manufacturing in the US over the next ...

GSK has announced a $30 billion investment in the U.S. over five years to enhance R&D and manufacturing, focusing on ...

British pharmaceutical giant GlaxoSmithKline (GSK) has announced a massive $30 billion investment in the United States. The ...

The FTSE 100 recovered ground on Wednesday, supported by gains in utilities and housebuilders, even as mining stocks lagged.

British pharmaceutical group GlaxoSmithKline PLC (GSK) plans to invest US$30 billion in the US over the next five years, it ...